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Effective antitumor immune response depends on the interaction between several 
components of the immune system, including antigen-presenting cells, antibodies, 
complement and different T cell subsets. Cancer cells have developed multiple 
strategies to modulate our immune system for evasion. Recent advances in cancer 
immunology allow for a better understanding of the mechanisms tumors use to execute 
immune escape and of the relationship the tumor establishes with immune cells. Many 
cellular and molecular events reflect that the tumor undergoes a continuous remodeling 
at the genetic, epigenetic and metabolic level to acquire resistance to cell killing 
mechanisms by complement and apoptosis. Malignant cells effectively employ literally all 
the components of the host's immune system to escape from their antitumor effects.This 
includes the accumulation of suppressive cells like Treg and myeloid derived suppressor 
cells as well as the release of inhibitory factors into the microenvironment. 
Furthermore, tumor-propagating cells must also escape from immune-mediated 
destruction. The ability to persist and to initiate neoplastic growth in the presence of 
immunosurveillance is decisive for the survival of cancer stem cells. After a general 
overview this presentation will exemplarily provide a deeper insight into strategies how 
cancer cells escape immune recognition and how these mechanisms can be neutralized 
with potential impact on tumor immunotherapy. 
 
